Medicare Drug Price Negotiation Not A Major Threat To Pharma – Even If It Passes

Biopharma analysts discuss the likely impact of the drug pricing reform provisions in the Build Back Better legislation, which has hit a roadblock created by Democratic Senator Joe Manchin of West Virginia.